[Federal Register Volume 68, Number 116 (Tuesday, June 17, 2003)]
[Notices]
[Pages 35913-35915]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-15203]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated January 27, 2003, and published in the Federal
Register on February 6, 2003 (68 FR 6181), AccuStandard, Inc., 125
Market Street, New Haven, Connecticut 06513, made application by letter
to the Drug Enforcement Administration (DEA) for registration as a bulk
manufacturer of the basic classes of controlled substances listed
below:
[[Page 35914]]
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)................................. I
Methcathinone (1237)............................. I
Aminorex (1585).................................. I
Gamma hydroxybutyric acid (2010)................. I
Methaqualone (2565).............................. I
Ibogaine (7260).................................. I
Lysergic acid diethylamide (7315)................ I
Tetrahydrocannabinols (7370)..................... I
Mescaline (7381)................................. I
4-Bromo-2, 5-dimethoxyamphetamine (7391)......... I
4-Bromo-2, 5-dimethoxyphenethylamine (7392)...... I
4-Methyl-2, 5-dimethoxyamphetamine (7395)........ I
2, 5-Dimethoxyamphetamine (7396)................. I
3, 4-Methylenedioxyamphetamine (7400)............ I
N-Hydroxy-3, 4-methylenedioxyamphetamine (7402).. I
3, 4-Methylenedioxy-N-ethylamphetamine (7404).... I
3, 4-Methylenedioxymethamphetamine (7405)........ I
4-Methoxyamphetamine (7411)...................... I
Bufotenine (7433)................................ I
1-[1-(2-Thienyl) cyclohexyl]piperidine (7470).... I
Codeine-N-oxide (9053)........................... I
Dihydromorphine (9145)........................... I
Heroin (9200).................................... I
Morphine-N-oxide (9307).......................... I
Normorphine (9313)............................... I
Etonitazene (9624)............................... I
Amphetamine (1100)............................... II
Methamphetamine (1105)........................... II
Phenmetrazine (1631)............................. II
Methylphenidate (1724)........................... II
Amobarbital (2125)............................... II
Pentobarbital (2270)............................. II
Secobarbital (2315).............................. II
Glutethimide (2550).............................. II
Phencyclidine (7471)............................. II
Alphaprodine (9010).............................. II
Anileridine (9020)............................... II
Cocaine (9041)................................... II
Codeine (9050)................................... II
Diprenorphine (9058)............................. II
Dihydrocodeine (9120)............................ II
Hydromorphone (9150)............................. II
Diphenoxylate (9170)............................. II
Benzoylecgonine (9180)........................... II
Ecgonine (9180).................................. II
Hydrocodone (9193)............................... II
Levorphanol (9220)............................... II
Methadone (9250)................................. II
Morphine (9300).................................. II
Thebaine (9333).................................. II
Opium, raw (9600)................................ II
Opium tincture (9630)............................ II
Opium powdered (9639)............................ II
Levo-alphacetylmethadol (9648)................... II
Oxymorphone (9652)............................... II
Alfentanil (9737)................................ II
Sufentanil (9740)................................ II
Fentanyl (9801).................................. II
------------------------------------------------------------------------
The firm plans to manufacture small quantities of the listed
controlled substances to make reference standards.
No comments or objections have been received. DEA has considered
the factors in title 21, United States code, section 823(a) and
determined that the registration of AccuStandard, Inc. to manufacture
the listed controlled substances is consistent with the public interest
at this time. DEA has investigated AccuStandard, Inc. to ensure that
the company's registration is consistent with the public interest. This
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and
0.104, the Deputy Assistant Administrator, Office of Diversion Control,
hereby orders that the application submitted by the above firm for
registration as a bulk manufacturer of the basic classes of controlled
substances listed above is granted
[[Page 35915]]
Dated: June 6, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 03-15203 filed 6-16-03; 8:45 am]
BILLING CODE 4410-09-M
